BIOMIMESYS
LIVE

Serial Number

79158828

Owner

CELENYS

Attorney

G MATHEW LOMBARD

Filing Date

Sep 29, 2014

Add to watchlist:

No watchlists yet
View on USPTO

BIOMIMESYS Trademark

Serial Number: 79158828 • Registration: 5028994

BIOMIMESYS is a trademark filed by CELENYS on September 29, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CELENYS (2 trademarks)

75 route de Lyons la Foret

Entity Type: 99

HCS PHARMA

250 rue Salvadore Allende,

Entity Type: 99

NETRI

76 rue Georges Gouy

Entity Type: 98

Trademark Details

Filing Date

September 29, 2014

Registration Date

August 30, 2016

Published for Opposition

June 14, 2016

Goods & Services

Pharmaceutical and veterinary products, namely, matrix for cell culture in the nature of cell growth media for growing cells for medical or clinical use, and for injectable biological tissue fillers for medical and veterinary purposes in the field of scientific research, medicine and tissue engineering; plasters for medical purposes; chemical preparations for pharmaceutical or medical purposes, namely, matrix for cell culture in the nature of cell growth media for growing cells for medical or clinical use, and for injectable biological tissue fillers for medical and veterinary purposes in the field of scientific research, medicine and tissue engineering; amino acids for medical use; adhesive bands for medical purposes; bandages for dressings; biological preparations for medical and veterinary use, namely, biological preparations for use in cell culture in the field of scientific research, medicine and tissue engineering; stem cells for medical use and for veterinary use; chemical preparations for medical, pharmaceutical and veterinary use, namely, matrix for cell culture in the nature of cell growth media for growing cells for medical or clinical use, and for injectable biological tissue fillers for medical and veterinary purposes in the field of scientific research, medicine and tissue engineering; culture media for use in augmentation of bone and tissue for medical purposes; Culture media for medical use, namely, for cultivating human cells, namely, primary and stem cells; biological tissue cultures for medical use; biological tissue cultures for veterinary use; Diagnostic preparations for medical purposes, namely, for diseases detection; medicines for dental use; medicines for veterinary use; medicines for human medicine; chemical reagents for medical or veterinary use; hyaluronic acid and polylactic acid for pharmaceutical purposes

[ Surgical, medical, dental and veterinary apparatus and instruments, namely, bone void filler consisting of synthetic materials; implants consisting of artificial materials; orthopedic bandages for joints, namely, orthopedic support bandages; surgical sponges; artificial skin for surgical use ]

Evaluations, assessments and research in the fields of science and technology provided by engineers, namely, scientific research; research and development of new products for others; technical project study in the nature of chemical and biological project management services, namely, biological and chemical research and analysis; chemical analysis; chemical research; chemistry consultation; quality control for others; testing of materials; scientific study and research in the fields of scientific research and tissue engineering; scientific laboratory services; biological research; bacteriological research; cosmetic research; technical research in the field of scientific research and tissue engineering

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Dec 25, 2025 CHLD
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Aug 30, 2025 REM4
INTERNATIONAL REGISTRATION RENEWED
Oct 31, 2024 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Dec 18, 2023 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Nov 14, 2023 INPS
INVALIDATION PROCESSED
Nov 14, 2023 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 10, 2023 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Mar 10, 2023 NA71
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Mar 10, 2023 NA15
REGISTERED - SEC. 15 ACKNOWLEDGED
Mar 10, 2023 15AK
REGISTERED - PARTIAL SEC 71 ACCEPTED
Mar 10, 2023 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 7, 2023 APRE
TEAS SECTION 71 RECEIVED
Aug 29, 2022 ES71
TEAS SECTION 15 RECEIVED
Aug 29, 2022 E15R
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 30, 2021 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Nov 27, 2020 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 16, 2020 NREP
CHANGE OF OWNER RECEIVED FROM IB
Nov 7, 2019 CHLD
NOTIFICATION PROCESSED BY IB
Jun 16, 2017 GPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 23, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 1, 2016 FICS
FINAL DISPOSITION PROCESSED
Dec 1, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 30, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 30, 2016 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 8, 2016 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 22, 2016 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 22, 2016 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 14, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jun 14, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 25, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 25, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 25, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 9, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 28, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 28, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 28, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 28, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 28, 2016 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 4, 2016 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 29, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 29, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 29, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 29, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 29, 2016 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 27, 2015 GNFN
FINAL REFUSAL E-MAILED
Aug 27, 2015 GNFR
FINAL REFUSAL WRITTEN
Aug 27, 2015 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 27, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 27, 2015 CRFA
ASSIGNED TO LIE
Jul 20, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 10, 2015 TROA
REFUSAL PROCESSED BY IB
Feb 27, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 11, 2015 RFCS
REFUSAL PROCESSED BY MPU
Feb 11, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 10, 2015 RFCR
NON-FINAL ACTION WRITTEN
Feb 9, 2015 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 27, 2015 MAFR
ASSIGNED TO EXAMINER
Jan 23, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 23, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 22, 2015 REPR